Competition Heats Up From New Market Entrants in New Era of Consumer Telehealth

The telehealth boom that was propelled by the COVID-19 pandemic has consolidated at levels lower than at the peak of the pandemic in April 2020, but significantly higher than levels seen before the pandemic. Consumer demand remains strong and will grow over time. McKinsey found that two of five surveyed consumers reported that they will continue to use telehealth going forward. As telehealth goes mainstream, the market represents both opportunities and challenges for traditional video telehealth platform vendors, such as Teladoc, Amwell, and MDLIVE, as well as healthcare providers. Both now face an unprecedented challenge from non-traditional players for control of the patient in terms of how and when they access medical care.

Fueled by unprecedented levels of venture capital investment, new entrants have entered the telehealth market. The competition is not just from competing video telehealth platforms. Some companies are competing for the same service revenue, but with alternative virtual care service models. An example is remote patient monitoring that allows for the transfer of patient data to a remote provider for monitoring and support in the care management of chronic conditions as appropriate.

A 2021 survey of 7,980 US adults conducted by Rock Health and Stanford Center for Digital Health identified the new paradigms disrupting conventional telehealth market parameters as follows:

  • Telehealth as a tool within a comprehensive suite of virtual care offerings to engage patients and providers in managing care and realizing outcomes.
  • Virtual-first care as part of an omnichannel experience that supplements and complements, rather than replaces in-person care across settings.
  • Telehealth for more targeted user segments (e.g., women) and specialized clinical needs (e.g., reproductive health), or both (e.g., adolescent behavioral health).

Although satisfaction among survey respondents is high, retail giants, such as Walmart, CVS, and Amazon, have entered the market, which could see them capture market opportunities that still exist to create value through personalized virtual care experiences and need fulfillment:

  • Walmart’s purchase of multi-specialty telehealth provider MeMD will allow it to provide virtual care services, including urgent care, behavioral health, and primary care to consumers nationwide. Walmart previously partnered with telehealth providers (i.e., Doctor on Demand, 98point6, and Ro) to provide virtual care to its 1.6 million employees in the US. The shift to virtual care is part of Walmart’s larger consumer health strategy, which includes in-store Walmart Health services offering transparent pricing, licensed healthcare staff, and a variety of primary, dental, optometry, and behavioral health care services, and integration with the retail aspect of consumer health and wellness products.
  • After Amazon’s initial foray into telehealth to first serve the needs of its employees, it has expanded its virtual care services as a virtual health service benefit to employers through Amazon Care. In addition to providing in-person primary care visits and prescription delivery at patients’ homes or offices, Amazon Care offers virtual visits via chat or video conference to expand access to primary, preventative, and urgent care 7 days a week, 365 days a year. Available to employees and employers nationwide, Amazon is initially targeting denser metropolitan statistical areas to ensure that individuals using its Amazon Care service have immediate access to in-person care if needed within 60 minutes of their GPS location.
  • Traditional healthcare providers are also under threat from traditional pharmacy retailers, such as CVS Health and Walgreens, which have also been expanding their virtual care services. CVS Health announced a “digital-first, technology-forward” strategy that builds on the decision to pivot the store footprint to focus on advanced primary care centers, enhanced HealthHUB locations, and traditional pharmacy stores. The company’s strategy to deliver omnichannel health services and offerings to meet the needs of 35 million online members when and where they want them will offer significant opportunities to enhance CX, improve efficiencies, and lower costs.

Author Information

Avatar photo

Andrew Broderick is a Senior Analyst contributing to Dash Research’s CX Advisory Service as well as Dash Network’s ongoing editorial coverage of Healthcare CX and Patient Experience. Based in San Francisco, Broderick has more than 20 years’ experience in technology research, analysis, and consulting, including an extensive background in digital health technologies and business practices.

Latest Insights:
Cohere Acquires Aleph Alpha: A Deal Born of Sovereignty & Necessity
April 27, 2026
Article
Article

Cohere Acquires Aleph Alpha: A Deal Born of Sovereignty & Necessity

Nick Patience, VP & Practice Lead at Futurum, analyses the Cohere and Aleph Alpha deal, examining strategic synergies, sovereign AI positioning, and key integration risks for the combined transatlantic enterprise AI company....
Meta’s AWS Pact Reframes the Graviton CPU as an AI Workhorse
April 27, 2026
Article
Article

Meta’s AWS Pact Reframes the Graviton CPU as an AI Workhorse

Brendan Burke, Research Director at Futurum, examines Meta's agreement with AWS to deploy tens of millions of Graviton cores, signaling a shift toward purpose-built CPUs as critical infrastructure for scaling agentic AI....
Will Edison International’s Board Refresh Accelerate Its AI and Digital Ambitions?
April 25, 2026

Will Edison International’s Board Refresh Accelerate Its AI and Digital Ambitions?

Edison International appoints M. Susan Hardwick as independent director, strengthening the utility's leadership as it confronts mounting pressure to modernize operations and leverage AI-driven infrastructure solutions....
Will GPT-5.5 Redefine Enterprise AI, or Hit the Limits of Trust and Control?
April 25, 2026

Will GPT-5.5 Redefine Enterprise AI, or Hit the Limits of Trust and Control?

OpenAI's GPT-5.5 launches as a transformative enterprise AI platform, yet adoption barriers around trust, reliability, and data privacy remain critical concerns for 78% of organizations planning AI budget increases....
Latest Research:
Closing the AI Confidence Gap: Cloud-Native Security as a Key to Agentic AI Adoption
April 23, 2026

Closing the AI Confidence Gap: Cloud-Native Security as a Key to Agentic AI Adoption

In our latest market report, Closing the AI Confidence Gap: Cloud-Native Security as a Key to Agentic AI Adoption, completed in partnership with Google Cloud, Futurum Research explores how enterprises...
Gemini Enterprise: Governing and Scaling the Agentic Enterprise
April 23, 2026

Gemini Enterprise: Governing and Scaling the Agentic Enterprise

In our latest market report, Gemini Enterprise: Governing and Scaling the Agentic Enterprise, completed in partnership with Google Cloud, Futurum Research examines the operational, governance, and lifecycle requirements for scaling...
Data Fitness for AI-Driven Operations
April 20, 2026
Research
Research

Data Fitness for AI-Driven Operations

In our latest market brief, Data Fitness for AI-Driven Operations, completed in partnership with NETSCOUT, Futurum Research explores why observability alone is insufficient as AI moves toward autonomous execution, and...

Book a Demo

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.